Skip to main content

Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:30 a.m. ET.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005849/en/

Scipher Medicine CEO Alif Saleh (Photo: Business Wire)

Scipher Medicine CEO Alif Saleh (Photo: Business Wire)

Conference participants can view the presentation through J.P. Morgan’s EventCenter.

About Scipher Medicine®

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, our proprietary network medicine platform, we commercialize tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

Contacts

Scipher Medicine:

Media Relations

Matt Burns

VP, Head of Communications

PR@scipher.com

518-423-5907

Investor Relations

John Strumbos, Ph.D., MBA

Chief Financial Officer

IR@scipher.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.